Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: New developments from the DANBIO registry

Merete Lund Hetland; Niels Steen Krogh; Kim Hørslev-Petersen; Berit Schiøttz-Christensen; Inge Juul Sørense; Dorte Vendelbo Jensen

Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: New developments from the DANBIO registry

Merete Lund Hetland^*, Niels Steen Krogh, Kim Hørslev-Petersen, Berit Schiøttz-Christensen, Inge Juul Sørense, Dorte Vendelbo Jensen

^*Corresponding author for this work

Department of Clinical Medicine

6 Citations (Scopus)

Abstract

Objective. Electronic platforms have been developed to help the clinician monitor disease activity in rheumatoid arthritis (RA) to support at treat-to-target strategy. We present an initiative to interactively improve disease control in patients with rheumatoid arthritis. Methods. In patients who presented with one or more swollen joints AND moderate/high disease activity (i.e. either CDAI≥10.1 and/or DAS- 28CRP > 3.2, which is automatically calculated in the DANBIO registry), a red alert was shown, which activated a pop-up: "This patient has at least one swollen joint AND either CDAI≥ 10.1 or DAS28CRP > 3.2. Which action do you as a physician take today: □ Intensify treatment, □Treatment intensification is not possible currently/awaiting results of additional investigations, □ No further treatment intensification is possible, □ The patient does not want to intensify treatment, □ Other decisions taken" Results. Of 21,056 patients with RA, 40% fulfilled the criteria for getting the alert message. The pop-up was activated and completed by the physician in 65% of those (5,428 patients). Treatment was intensified in 67%. In 2% of patients, no additional treatment intensification was possible, and 8% of the patients objected to intensification. Conclusion. In > 8,000 RA patients who presented with objective signs of active disease in routine care, an interactive feature of the DANBIO registry was introduced, which prompted the physician to take action and consider treatment intensification. In two-thirds of the cases, the treating physician reported that treatment was intensified.

Original language	English
Journal	Clinical and Experimental Rheumatology
Volume	34
Issue number	S101
Pages (from-to)	75-78
Number of pages	4
ISSN	0392-856X
Publication status	Published - 2016

Keywords

DANBIO registry
Interactive electronic platform
Rheumatoid arthritis

Access to Document

http://www.clinexprheumatol.org/article.asp?a=11140Licence: Unspecified

Cite this

Hetland, M. L., Krogh, N. S., Hørslev-Petersen, K., Schiøttz-Christensen, B., Sørense, I. J., & Jensen, D. V. (2016). Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: New developments from the DANBIO registry. Clinical and Experimental Rheumatology, 34(S101), 75-78. http://www.clinexprheumatol.org/article.asp?a=11140

Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis : New developments from the DANBIO registry. / Hetland, Merete Lund; Krogh, Niels Steen; Hørslev-Petersen, Kim et al.

In: Clinical and Experimental Rheumatology, Vol. 34, No. S101, 2016, p. 75-78.

Research output: Contribution to journal › Journal article › Research › peer-review

Hetland, ML, Krogh, NS, Hørslev-Petersen, K, Schiøttz-Christensen, B, Sørense, IJ & Jensen, DV 2016, 'Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: New developments from the DANBIO registry', Clinical and Experimental Rheumatology, vol. 34, no. S101, pp. 75-78. <http://www.clinexprheumatol.org/article.asp?a=11140>

@article{1112dea759e34168984eea8cb95d154c,

title = "Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: New developments from the DANBIO registry",

abstract = "Objective. Electronic platforms have been developed to help the clinician monitor disease activity in rheumatoid arthritis (RA) to support at treat-to-target strategy. We present an initiative to interactively improve disease control in patients with rheumatoid arthritis. Methods. In patients who presented with one or more swollen joints AND moderate/high disease activity (i.e. either CDAI≥10.1 and/or DAS- 28CRP > 3.2, which is automatically calculated in the DANBIO registry), a red alert was shown, which activated a pop-up: {"}This patient has at least one swollen joint AND either CDAI≥ 10.1 or DAS28CRP > 3.2. Which action do you as a physician take today: □ Intensify treatment, □Treatment intensification is not possible currently/awaiting results of additional investigations, □ No further treatment intensification is possible, □ The patient does not want to intensify treatment, □ Other decisions taken{"} Results. Of 21,056 patients with RA, 40% fulfilled the criteria for getting the alert message. The pop-up was activated and completed by the physician in 65% of those (5,428 patients). Treatment was intensified in 67%. In 2% of patients, no additional treatment intensification was possible, and 8% of the patients objected to intensification. Conclusion. In > 8,000 RA patients who presented with objective signs of active disease in routine care, an interactive feature of the DANBIO registry was introduced, which prompted the physician to take action and consider treatment intensification. In two-thirds of the cases, the treating physician reported that treatment was intensified.",

keywords = "DANBIO registry, Interactive electronic platform, Rheumatoid arthritis",

author = "Hetland, {Merete Lund} and Krogh, {Niels Steen} and Kim H{\o}rslev-Petersen and Berit Schi{\o}ttz-Christensen and S{\o}rense, {Inge Juul} and Jensen, {Dorte Vendelbo}",

year = "2016",

language = "English",

volume = "34",

pages = "75--78",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Pacini Editore SpA",

number = "S101",

}

TY - JOUR

T1 - Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis

T2 - New developments from the DANBIO registry

AU - Hetland, Merete Lund

AU - Krogh, Niels Steen

AU - Hørslev-Petersen, Kim

AU - Schiøttz-Christensen, Berit

AU - Sørense, Inge Juul

AU - Jensen, Dorte Vendelbo

PY - 2016

Y1 - 2016

N2 - Objective. Electronic platforms have been developed to help the clinician monitor disease activity in rheumatoid arthritis (RA) to support at treat-to-target strategy. We present an initiative to interactively improve disease control in patients with rheumatoid arthritis. Methods. In patients who presented with one or more swollen joints AND moderate/high disease activity (i.e. either CDAI≥10.1 and/or DAS- 28CRP > 3.2, which is automatically calculated in the DANBIO registry), a red alert was shown, which activated a pop-up: "This patient has at least one swollen joint AND either CDAI≥ 10.1 or DAS28CRP > 3.2. Which action do you as a physician take today: □ Intensify treatment, □Treatment intensification is not possible currently/awaiting results of additional investigations, □ No further treatment intensification is possible, □ The patient does not want to intensify treatment, □ Other decisions taken" Results. Of 21,056 patients with RA, 40% fulfilled the criteria for getting the alert message. The pop-up was activated and completed by the physician in 65% of those (5,428 patients). Treatment was intensified in 67%. In 2% of patients, no additional treatment intensification was possible, and 8% of the patients objected to intensification. Conclusion. In > 8,000 RA patients who presented with objective signs of active disease in routine care, an interactive feature of the DANBIO registry was introduced, which prompted the physician to take action and consider treatment intensification. In two-thirds of the cases, the treating physician reported that treatment was intensified.

AB - Objective. Electronic platforms have been developed to help the clinician monitor disease activity in rheumatoid arthritis (RA) to support at treat-to-target strategy. We present an initiative to interactively improve disease control in patients with rheumatoid arthritis. Methods. In patients who presented with one or more swollen joints AND moderate/high disease activity (i.e. either CDAI≥10.1 and/or DAS- 28CRP > 3.2, which is automatically calculated in the DANBIO registry), a red alert was shown, which activated a pop-up: "This patient has at least one swollen joint AND either CDAI≥ 10.1 or DAS28CRP > 3.2. Which action do you as a physician take today: □ Intensify treatment, □Treatment intensification is not possible currently/awaiting results of additional investigations, □ No further treatment intensification is possible, □ The patient does not want to intensify treatment, □ Other decisions taken" Results. Of 21,056 patients with RA, 40% fulfilled the criteria for getting the alert message. The pop-up was activated and completed by the physician in 65% of those (5,428 patients). Treatment was intensified in 67%. In 2% of patients, no additional treatment intensification was possible, and 8% of the patients objected to intensification. Conclusion. In > 8,000 RA patients who presented with objective signs of active disease in routine care, an interactive feature of the DANBIO registry was introduced, which prompted the physician to take action and consider treatment intensification. In two-thirds of the cases, the treating physician reported that treatment was intensified.

KW - DANBIO registry

KW - Interactive electronic platform

KW - Rheumatoid arthritis

M3 - Journal article

AN - SCOPUS:85018322509

SN - 0392-856X

VL - 34

SP - 75

EP - 78

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - S101

ER -

Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: New developments from the DANBIO registry

Abstract

Keywords

Access to Document

Fingerprint

Cite this